BOK Financial Private Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-140
Closed -$4.03K 470
2024
Q1
$4.03K Hold
140
﹤0.01% 411
2023
Q4
$4.59K Buy
+140
New +$3.81K ﹤0.01% 405

Other funds holding ARKG

BOK Financial Private Wealth's ARKG Position: Q2 2024 in Review

BOK Financial Private Wealth sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 140 shares — an estimated $4.03K sold.

BOK Financial Private Wealth first reported a position in ARKG in Q4 2023 and held it in 2 quarters. The position peaked at $4.59K in Q4 2023. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • BOK Financial Private Wealth reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • BOK Financial Private Wealth sold 140 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $4.03K.
  • BOK Financial Private Wealth first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 2 quarters.
  • BOK Financial Private Wealth's ARK Genomic Revolution ETF position peaked at $4.59K in Q4 2023.
  • 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on BOK Financial Private Wealth's 13F filing for Q2 2024, filed 14 Aug 2024.